Changes in Hong Kong stocks | Kaituo Pharmaceutical-B (09939) rose more than 5%, losses in the first half of the year narrowed year on year, and sales of cosmetics led to a surge in revenue

The Zhitong Finance App learned that Kaituo Pharmaceutical-B (09939) rose by more than 5%. As of press release, it had risen 5.56% to HK$1.71, with a turnover of HK$3.6581 million.

According to the news, Kaituo Pharmaceutical's 2026 interim results show that revenue increased from 6 million yuan in the same period last year to 52 million yuan for the six months ending June 30, 2026, with a net loss of 75.782 million yuan, a year-on-year decrease of 8.99%. According to the announcement, the increase in revenue was mainly due to live e-commerce sales driving global sales of the new high-end cosmetics brand KOSHINÉ (KX-826, the main ingredient of which is one of the company's core products). The decrease in net loss was mainly due to a reduction in R&D costs, partly offset by an increase in sales and marketing expenses, mainly due to increased marketing and promotion expenses.